Advertisement

Topics

UroGenRA - Genitourinary cancer array - Biotech, Pharma and Life Science Channel

20:55 EDT 22nd July 2017 | BioPortfolio

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It was designed to detect gains and losses that frequently occur in these three cancer types and that have the potential to differentially diagnose and/or stratify patients to assist and guide clinical management. For kidney cancer, it is specifically designed to classify tumors into the four main types (three malignant, one benign) critical at several levels in patient management: diagnosis of image-guided needle biopsies of small incidentally discovered kidney masses providing rationale for surgical/non-surgical management,  diagnosis in patients with larger neoplasms to stratify for risks of local or regionally advanced disease that can be factored in to treatment selection recommendations (i.e., extent of surgical intervention, less invasive options or ablation), in those with metastatic disease, where drug trials are currently based on post-surgical tumor diagnosis, and potentially in the diagnosis of the so-called morphologically “unclassified” renal cancers. Additionally within the predominant subtype, clear cell renal cell carcinoma, prognostication is feasible based on the presence/absence of gain and loss of certain genomic regions. For prostate cancer, UroGenRA, has the potential to assess prostate core/needle biopsy genomic variability, to identify biomarker for inclusion in nomograms for assessment of risk of biochemical recurrence, to assess radiocurability and treatment options for intermediate risk patients, and to explore the genomic aberrations of circulating tumor cells. For bladder cancer, UroGenRA has application in identifying tumors most likely to recur, and of muscle-invasive lesions those most likely to benefit from treatment.

Source: http://cancergenetics.com/cgi-research/cgh-microarray/ UroGenRA is a Registered Trademark of CGI

PubMed Articles [16964 Associated PubMed Articles listed on BioPortfolio]

Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.

A patient's medical history and familial cancer history are important information for assessing the risk of hereditary cancer. We have generated a self-administered questionnaire for patients with gyn...

Anal metastasis of rectal cancer-adenocarcinoma of squamous cells: a case report and literature review.

Anal metastasis of colorectal cancer is very rare and is usually associated with a history of anal disease, including anal fistula, fissure, hemorrhoidectomy, and anastomotic injury. We report a case ...

Transcatheter arterial embolization for intercostal arterio-esophageal fistula in esophageal cancer.

While esophageal fistula formation in the adjacent organs is associated with high rates of morbidity and mortality, the management of non-aortic arterio-esophageal fistula has not been frequently repo...

Should the FDA Ban Cigarette Filter Ventilation?

Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.

The 2014 Surgeon General's Report on smoking and health concluded that changing cigarette designs have caused an increase in lung adenocarcinomas, implicating cigarette filter ventilation that lowers ...

A fascia lata free flap in pelvic exenteration for Fournier gangrene due to advanced rectal cancer: a case report.

Fournier gangrene due to advanced rectal cancer is a rapidly progressive gangrene of the perineum and buttocks. Emergency surgical debridement of necrotic tissue is crucial, and secondary surgery to r...

Economic burden of cancer among patients with surgical resections of the lung, rectum, liver and uterus: results from a US hospital database claims analysis.

To determine hospital resource utilization, associated costs and the risk of complications during hospitalization for four types of surgical resections and to estimate the incremental burden among pat...

A CZT-based blood counter for quantitative molecular imaging.

Robust quantitative analysis in positron emission tomography (PET) and in single-photon emission computed tomography (SPECT) typically requires the time-activity curve as an input function for the pha...

Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer.

Molecular breast imaging (MBI) performed with (99m)Tc sestamibi has been shown to be a valuable technique for the detection of breast cancer. Alternative radiotracers such as (99m)Tc maraciclatide may...

Demonstration of Logic Operations in High-Performance RRAM Crossbar Array Fabricated by Atomic Layer Deposition Technique.

In this paper, resistive random access memory (RRAM)-based crossbar arrays with the cell structure of Pt/[AlO y /HfO x ] m /TiN were fabricated by using atomic layer deposition (ALD) technique. The RR...

News Articles [13959 Associated News Articles listed on BioPortfolio]

PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer

Avastin Drug Insights, 2017 [Report Updated: 10072017] Prices from USD $1000

DelveInsight's pharmaceuticals report, Avastin Drug Insights, 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report c...

HIV and cancer teams double up to seek out new disease killers

LONDON, (Reuters) - HIV experts at an international conference starting on Saturday are keenly courting colleagues in oncology to explore whether advances in harnessing the immune system against cance...

Senator McCain: Way Too Soon To Ask Him To Step Down

Here's Republican candidate Kelli Ward said about McCain and "stepping away as quickly as possible" after his cancer diagnosis.

Geneseeq Raises "Hundred of Millions of RMB" in C Round to Develop NGS

Geneseeq, a Nanjing-Toronto genetic sequencing company, closed a C funding round of "hundreds of millions of RMB," according to the company. Founded in 2008, Geneseeq focuses on genetic sequencing to ...

Roche's Tecentriq receives positive opinion from EU medicines agency

ZURICH (Reuters) - A European Medicines Agency (EMA) panel said on Friday it has recommended Roche's immunotherapy Tecentriq as a treatment for advanced bladder and lung cancer, setting the stage for ...

News digest – Tobacco strategy, cancer survival, HPV jab and boys, and finally… John McCain diagnosed with cancer

Science blog The government finally announced its ambition for a smokefree generation in England 2022. According to the BBC, Sun and New Scientist, the long-awaited Tobacco Control Plan aims t...

Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells

Senescent cells: an emerging target for diseases of ageing

Cellular senescence is causally linked to ageing and has been implicated in a variety of age-related diseases. Here, van Deursen and colleagues review the characteristics of senescent cells and highli...

Lee's Pharm and SillaJen Approved for China Immunotherapy Trial

Lee's Pharm received CFDA approval for a Phase III trial of Pexa-Vec in patients with advanced liver cancer. The study is part of the PHOCUS global trial that was started in 2015. Lee's Pharm owns Chi...

Events [0 Results]

None

Companies [678 Associated Companies listed on BioPortfolio]

Philogen

Philogen is a Swiss-Italian clinical-stage company engaged in the discovery and development of novel pharmaceutical and biopharmaceutical products. Philogen’s strategy is to ...

Veracyte, Inc.

Veracyte is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable...

Abzena plc and Telix Pharmaceuticals Limited

“Radio-immunoconjugates have tremendous potential as one of the most adaptable site specific, precision medicines and, in prostate cancer, PSMA is increasingly recognised as ...

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in...

Samumed, LLC

Based in San Diego, CA, Samumed (www.samumed.com) is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and in...

StemSynergy Therapeutics, Inc.

StemSynergy is a privately held biopharmaceutical company that focuses on the discovery and development of drugs targeting developmental pathways fundamental to cancer. For more i...

Lumicell, Inc.

Lumicell is a leader in the field of image-guided cancer surgery. The company is developing a revolutionary intraoperative imaging system that gives surgeons real-time visual feed...

Helix BioMedix, Inc

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our co...

Dendreon Pharmaceuticals LLC

Dendreon is a healthcare company whose mission is to transform lives through the discovery, development, commercialization and manufacturing of novel personalized immune-therapeut...

Arrien Pharmaceuticals

Arrien Pharmaceuticals is a targeted therapeutics drug discovery and development company. Arrien applies its proprietary fragment-based FIELDS drug discovery technology to targ...

Clinical Trials [6124 Associated Clinical Trials listed on BioPortfolio]

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

This is a Phase II study of pembrolizumab plus mifepristone in advanced breast cancer patients. The study will include a safety lead in of ten patients. Patients who are deemed eligible an...

Cranial Osteopathic Manipulative Medicine as an Adjunct Treatment for Concussion

Patients who have concussions exhibit an array of symptoms, also known as post-concussive symptoms, including headaches, feeling slowed down or foggy and difficulty with concentration. Thi...

Patient Navigation to Improve Patient-Centered Cancer Care

The MGH Cancer Center's patient navigation (PN) program, utilizes specially trained community-based personnel to improve cancer care in underserved communities by increasing cancer screeni...

Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer

In this study, PLD, an anthracycline encapsulated in stealth liposomes, which are believed to efficiently deliver the doxorubicin within the tumour mass with less toxicity compared with st...

Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle

At present, the evaluation criterion of endometrial receptivity is controversial. The development of a molecular diagnostic tool, the endometrial receptivity array (ERA) for diagnosis of e...

HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individua...

Transcriptomic Profile of Endometrium in Different Histological Dating of Hormone Replacement Cycle

At present, the evaluation criterion of endometrial receptivity is controversial. The development of a molecular diagnostic tool, the endometrial receptivity array (ERA) for diagnosis of e...

Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

The purpose of this study is to test the safety of a combination of three drugs, pembrolizumab, guadecitabine and mocetinostat. Pembrolizumab is a drug given by vein and all patients will ...

Comprehensive Yoga Program (SKY) as Adjunct Therapy for Prostate Cancer

This randomized pilot trial studies the effect of comprehensive yoga program (SKY) in reducing stress, pain, and fatigue, and improving psychological well-being in patients with prostate c...

MRG HIFU With Radiotherapy for Palliation of H&N Cancer

Head and neck cancer is the sixth most common form of malignancy world-wide. Surgery, chemotherapy and radiation are associated with a high burden of side effects; tumour recurrence within...

Videos

None available.

Medical and Biotech [MESH] Definitions

The simultaneous analysis of multiple samples of TISSUES or CELLS from BIOPSY or in vitro culture that have been arranged in an array format on slides or microchips.

A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)

A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.

A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.

A contiguous gene syndrome associated with hemizygous deletions of chromosome region 11p13. The condition is marked by the combination of WILMS TUMOR; ANIRIDIA; GENITOURINARY ABNORMALITIES; and MENTAL RETARDATION.

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...

review and buy UroGenRA - Genitourinary cancer array market research data and corporate reports here

Channels Quicklinks